Noninvasive adrenal imaging in hyperaldosteronism

Current Urology Reports

Volumn 9, Issue 1, 2008, Pages 80-87

  Simon, Daniel R ^a   Palese, Michael A ^b  

^a MOUNT SINAI HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; ALDOSTERONE; CONTRAST MEDIUM; RADIOISOTOPE;

ADENOMA; ADRENAL HYPERPLASIA; ADRENAL INSUFFICIENCY; ADRENAL SCINTISCANNING; ADRENALECTOMY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; HUMAN; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIMARY HYPERALDOSTERONISM; REVIEW; VEIN CATHETERIZATION; VEIN THROMBOSIS;

ALGORITHMS; HUMANS; HYPERALDOSTERONISM; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38349080037     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0015-2     Document Type: Review

References (44)

1. Conn JW: Primary Aldosteronism. J Lab Clin Med 1955, 45:661-664.
2. Khan U, Gomez-Sanchez CE: Primary aldosteronism: evolving concepts in diagnosis and treatment. Curr Opin Endocrinol Diabetes 2004, 11:153-157.
3. Moneva MH, Gomez-Sanchez CE: Establishing a diagnosis of primary hyperaldosteronism. Curr Opin Endocrinol Diabetes 2001, 8:124-129.
4. •• Rossi GP, Bernini G, Caliumi C, et al.: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006, 48(11):2293-2300. A prospective review of a large series of hypertensive patients looking at trends in primary aldosteronism.
5. Mulatero P, Stowasser M, Loh KC, et al.: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004, 89(3):1045- 1050.
6. Harris DA, Au-Yong I, Basnyat PS, et al.: Review of surgical management of aldosterone secreting tumours of the adrenal cortex. Eur J Surg Oncol 2003, 29:467-474.
7. Young WF: Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003, 144(6):2208-2213.
8. Rossi GP, Sacchetto A, Chiesura-Corona M, et al.: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001, 86(3):1083-1090.
9. Darracott V, Blumenfeld JD: Pathophysiology, evaluation, and medical management of adrenal disorders. In Campbell-Walsh Urology. Edited by Wein AJ. Philadelphia: Saunders Elsevier; 2007:1821-1868.
10. Radin DR, Manoogian C, Nadler JL: Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. AJR Am J Roentgenol 1992, 158:553-557.
11. Sohaib SAA, Reznek RH: Adrenal imaging. BJU Int 2000, 86(Suppl 1):95-110.
12. Geisinger MA, Zelch MG, Bravo EL, et al.: Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling. AJR Am J Roentgenol 1983, 141:299-302.
13. Magill S, Raff H, Shaker JL, et al.: Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001, 86(3):1066-1071.
14. Sohaib SAA, Bomanji J, Evanson J, et al.: Imaging of the endocrine system. In Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging. Edited by Grainger RG. London; Harcourt Publishers Limited; 2001:1385-1393.
15. Dunnick NR, Leight GS, Roubidoux MA, et al.: CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. AJR Am J Roentgenol 1993, 160:321-324.
16. • Sohaib SA, Rockall AG, Reznek RH: Imaging functional adrenal disorders. Best Pract Res Clin Endocrinol Metab 2005, 19(2):293-310. Good review of radiographic techniques used in adrenal pathology.
17. Peppercorn PD, Reznek RH: State-of-the-art CT and MRI of the adrenal gland. Eur Radiol 1997, 7:822-836.
18. Young WF, Klee GG: Primary aldosteronism. Endocrinol Metab Clin North Am 1988, 17(2):367-395.
19. Ikeda DM, Francis IR, Glazer GM, et al.: The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT, and MR imaging. AJR Am J Roentgenol 1989, 153:301-306.
20. Lingam RK, Sohaib SA, Vlahos I, et al.: CT of Primary Hyperaldosteronism (Conn's Syndrome): The value of measuring the adrenal gland. AJR Am J Roentgenol 2003, 181:843-849.
21. Yamada T, Ishibashi T, Saito H, et al.: Adrenal adenomas: relationship between histologic lipid-rich cells and CT attenuation number. Eur J Radiol 2003, 48(2):198-202.
22. Caoili EM, Korobkin M, Francis IR, et al.: Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002, 222(3):629-633.
23. Reinig JW, Stutley JE, Leonhardt CM, et al.: Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994, 192(1):41-46.
24. Tsushima Y: Different lipid contents between aldosterone-producing and nonhyperfunctioning adrenocortical adenomas: in vivo measurement using chemical-shift magnetic resonance imaging. J Clin Endocrinol Metab 1994, 79(6):1759-1762.
25. • Lingam RK, Sohaib SA, Rockall AG, et al.: Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome). Eur Radiol 2004, 14(10):1787-1792. Good comparison of CT and MRI in detecting aldosterone-producing adenomas.
26. Sohaib SA, Peppercorn PD, Allan C, et al.: Primary hyperaldosteronism (Conn syndrome): MR imaging findings. Radiology 2000, 214(2):527-531.
27. Rossi GP, Chiesura-Corona M, Tregnaghi A, et al.: Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J Hum Hypertens 1993, 7(4):357-363.
28. Rubello D, Bui C, Casara D, et al.: Functional scintigraphy of the adrenal gland. Eur J Endocrinol 2002, 147:13-28.
29. Shapiro B, Grekin R, Gross MD, Freitas JE: Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism. Clin Nucl Med 1994, 19(5):441-445.
30. Nocaudie-Calzada M, Huglo D, Lambert M, et al.: Efficacy of iodine-131 6[INSERT BETA]-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med 1999, 26(10):1326-1332.
31. Shapiro B, Nakajo M, Gross MD, et al.: Value of bowel preparation in adrenocortical scintigraphy with NP-59. J Nucl Med 1983, 24(8):732-734.
32. Gross MD, Shapiro B, Grekin RJ, et al.: Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Med 1984, 77:839-844.
33. Gross MD, Freitas JE, Swanson DP, et al.: The normal dexamethasone-suppression adrenal scintiscan. J Nucl Med 1979, 20(11):1131-1135.
34. Guerin CK, Wahner HW, Gorman CA, et al.: Computed tomographic scanning versus radioisotope imaging in adrenocortical diagnosis. Am J Med 1983, 75:653-657.
35. Phillips JL, Walther MM, Pezzullo JC, et al.: Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000, 85(12):4526-4533.
36. Lumachi F, Marzola MC, Zucchetta P, et al.: Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun 2003, 24:683-688.
37. Leprat F, Olivier-Puel F, Laurent F, et al.: Diagnosis of Conn's adenoma. Comparative study of x-ray computed tomography and scintigraphy using 19-noriodocholesterol. Presse Med 1997, 26(31):1469-1473.
38. Sheaves R, Goldin J, Reznek RH, et al.: Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. Eur J Endocrinol 1996, 134:308-313.
39. Doppman JL, Gill JR, Miller DL, et al.: Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 1992, 184:677-682.
40. Harper R, Ferrett CC, McKnight JA, et al.: Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone- secreting adrenal adenomas. QJM 1999, 92:643-650.
41. Kazerooni EA, Sisson JC, Shapiro B, et al.: Diagnostic accuracy and pitfalls of [Iodine 131]6-Beta-Iodomethyl-19-Norcholesterol (NP-59) Imaging. J Nucl Med 1990, 31(4):526-534.
42. Freitas JE, Grekin RJ, Thrall JH, et al.: Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism. J Nucl Med 1979, 20(1):7-10.
43. Weinberger MH, Grim CE, Hollifield JW, et al.: Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 1979, 90(3):386-95.
44. Miles JM, Wahner HW, Carpenter PC, et al.: Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent. Mayo Clin Proc 1979, 54(5):321-327.